We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.41%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.1B
AUM Growth
+$345M
(+1.7%)
Cap. Flow
-$629M
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
30.49%
Holding
726
New
45
Increased
386
Reduced
252
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$153M |
| 2 |
GG
Goldcorp Inc
GG
|
+$135M |
| 3 |
B
Barrick Mining
B
|
+$83.5M |
| 4 |
FMC
FMC
|
+$71.4M |
| 5 |
Nabors Industries
NBR
|
+$67.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Occidental Petroleum
OXY
|
+$180M |
| 2 |
MON
Monsanto Co
MON
|
+$99.5M |
| 3 |
Archer Daniels Midland
ADM
|
+$98.2M |
| 4 |
Deere & Co
DE
|
+$86.9M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
+$83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 44.67% |
| 2 | Energy | 26.42% |
| 3 | Healthcare | 5.22% |
| 4 | Industrials | 4.4% |
| 5 | Consumer Staples | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Bristol-Myers Squibb
BMY
$127B
| $13.4M | 0.07% |
257,014
+7,092
| +3% | +$377K |
|
177
Bausch Health
BHC
$1.65B
| $13M | 0.06% |
98,488
-8,496
| -8% | -$1.16M |
|
178
United Therapeutics
UTHR
$26.3B
| $13M | 0.06% |
137,913
+2,859
| +2% | +$292K |
|
|
AGN
179
DELISTED
Allergan plc
AGN
| $13M | 0.06% |
62,943
+614
| +1% | +$122K |
|
|
GSS
180
DELISTED
Golden Star Resources Ltd.
GSS
| $12.6M | 0.06% |
4,160,010
+127,945
| +3% | +$427K |
|
181
AGNC Investment
AGNC
$12.3B
| $12.4M | 0.06% |
578,279
+117,823
| +26% | +$2.53M |
|
182
Tidewater
TDW
$3.91B
| $12.3M | 0.06% |
7,819
-272
| -3% | -$445K |
|
|
CRR
183
DELISTED
Carbo Ceramics Inc.
CRR
| $12.3M | 0.06% |
88,841
+11,011
| +14% | +$1.3M |
|
184
Broadcom
AVGO
$1.82T
| $12M | 0.06% |
1,860,100
+265,500
| +17% | +$1.56M |
|
185
Eaton
ETN
$157B
| $11.3M | 0.06% |
150,849
+29,019
| +24% | +$2.14M |
|
|
ALTR
186
DELISTED
Altera Corp
ALTR
| $10.5M | 0.05% |
289,137
+17,101
| +6% | +$587K |
|
|
SHPG
187
DELISTED
Shire pic
SHPG
| $10.2M | 0.05% |
68,400
+7,506
| +12% | +$1.16M |
|
|
JOY
188
DELISTED
Joy Global Inc
JOY
| $10.1M | 0.05% |
173,547
-29,094
| -14% | -$1.62M |
|
|
ICPT
189
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.62M | 0.05% |
+29,155
| New | +$9.84M |
|
190
First Solar
FSLR
$21.8B
| $9.61M | 0.05% |
137,735
+23,701
| +21% | +$1.32M |
|
191
Tesla
TSLA
$1.24T
| $9.59M | 0.05% |
690,360
-184,140
| -21% | -$2.47M |
|
192
Charles River Laboratories
CRL
$10.9B
| $9.34M | 0.05% |
154,834
+25,451
| +20% | +$1.48M |
|
|
AXU
193
DELISTED
Alexco Resource Corp
AXU
| $9.28M | 0.05% |
6,187,910
+3,023,248
| +96% | +$5.36M |
|
194
KLA
KLAC
$275B
| $9.26M | 0.05% |
1,339,350
-72,340
| -5% | -$468K |
|
195
NVIDIA
NVDA
$5.01T
| $9.03M | 0.04% |
20,168,480
+883,120
| +5% | +$378K |
|
|
MTCN
196
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $8.96M | 0.04% |
373,422
+49,110
| +15% | +$1.19M |
|
|
MDR
197
DELISTED
McDermott International
MDR
| $8.81M | 0.04% |
375,611
+51,294
| +16% | +$1.29M |
|
|
BTU
198
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $8.52M | 0.04% |
34,743
-1,304
| -4% | -$331K |
|
|
SUNE
199
DELISTED
SUNEDISON, INC COM
SUNE
| $8.32M | 0.04% |
441,723
+7,463
| +2% | +$124K |
|
200
Lam Research
LRCX
$382B
| $8.23M | 0.04% |
1,497,050
+120,690
| +9% | +$641K |
|
Similar funds
DAM
VanEck Associates's Q1 2014 Portfolio in Review
As of Q1 2014, VanEck Associates held 726 positions worth $20.1B, up 1.7% from $19.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
VanEck Associates withdrew a net $629M in Q1 2014, closing 32 positions and reducing 252 holdings. Its most notable exit was Halcon Resources Corporation, an estimated $33.5M position sold in full.
By sector, the portfolio is most concentrated in Materials at 45% of assets, up from 43% a quarter earlier, followed by Energy and Healthcare.
Against the trend, VanEck Associates opened a new position in FMC worth $72.9M.
- VanEck Associates's largest Q1 2014 buy was FMC: 1,097,354 shares worth $72.9M.
- VanEck Associates added most to Freeport-McMoran in Q1 2014, an estimated $153M increase.
- VanEck Associates's biggest Q1 2014 reduction was Occidental Petroleum, cutting an estimated $180M.
- VanEck Associates fully exited Halcon Resources Corporation in Q1 2014, selling an estimated $33.5M.
- VanEck Associates's ten largest holdings make up 30% of its $20.1B portfolio in Q1 2014.
- VanEck Associates opened 45 new positions and closed 32 in Q1 2014.
- VanEck Associates's portfolio value rose 1.7% quarter-over-quarter to $20.1B.
Based on VanEck Associates's 13F filing for Q1 2014, filed 8 May 2014.